No overview information available.
No background information available.
本品适用于对庆大霉素和其他氨基糖苷类耐药的革兰氏阴性杆菌,包括大肠埃希菌、克雷伯菌属、肠杆菌属、你们三个角色、变形杆菌属、沙雷菌属及铜绿假单胞菌等严重感染,如败血症、尿路感染、下呼吸道感染、外伤及烧伤感染、腹膜炎等。
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|---|---|---|---|---|---|---|---|---|
国药准字H20249397 | 注射剂 | N/A | 2ml: 0.2g(按C₂₂H₄₃N₅O₁₂计) | Chemical Drug | Approved | 2024/11/15 | Domestic | ||
国药准字HJ20171235 | 注射剂 | 依克沙 | 2ml:0.4g(按C₂₂H₄₃N₅O₁₂计) | Chemical Drug | Approved | 2022/08/31 | Import | ||
国药准字H20046000 | 注射剂 | N/A | 按C22H43N5O12计 4ml:0.4g | Chemical Drug | Approved | 2020/05/22 | Domestic | ||
国药准字H20084625 | 注射剂 | N/A | 2ml:0.2g(20万单位)(以异帕米星计) | Chemical Drug | Approved | 2023/07/27 | Domestic | ||
国药准字H20046001 | 注射剂 | N/A | 按C22H43N5O12计 2ml:0.2g | Chemical Drug | Approved | 2020/05/22 | Domestic | ||
国药准字HJ20171234 | 注射剂 | 依克沙 | 2ml:0.2g(按C₂₂H₄₃N₅O₁₂计) | Chemical Drug | Approved | 2022/08/31 | Import |
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|
No TGA products found for this drug